NanoVation Therapeutics™ Email Format

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

NanoVation Therapeutics is a biotechnology company focused on developing lipid nanoparticle technologies to improve nucleic acid delivery. Its lead platform enables distribution of functional nucleic acids to cell types outside the liver, aiming to broaden the reach and therapeutic index of genetic medicines. The company collaborates with pharmaceutical and biotech partners to advance genetic therapies for diseases that have been difficult to treat, including opportunities in cardiometabolic and rare diseases. Based in Vancouver, British Columbia, NanoVation operates in the biotechnology research sector, leveraging its expertise to address targeted delivery challenges in nucleic acid therapies. Recent activities include recognition for a notable industry deal and ongoing partnerships, reflecting its role in advancing next-generation genetic medicines.

Sign up for free to view info

Company overview Employee directory